Seizures in Down Syndrome: An Update

M M Rahman1, K Fatema

  • 1Professor Dr Md Mizanur Rahman, Chairman, Department of Pediatric Neurology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh.

Insights

Epilepsy is more common in individuals with Down syndrome (DS), with seizures often starting in infancy or later adulthood. Treatment follows general guidelines, but phenytoin may cause more side effects in DS patients.

Area of Science:

  • Neurology
  • Genetics
  • Developmental Pediatrics

Background:

  • Individuals with Down syndrome (DS) exhibit a higher prevalence of seizures compared to the general population, with rates ranging from 1-13%.
  • Seizure onset in DS can occur in infancy (40%) or later in life (40%), with males generally experiencing an earlier onset.
  • The prevalence of epilepsy in DS increases with age, affecting various age groups differently.

Purpose of the Study:

  • To describe the features of seizures in children with Down syndrome.
  • To review the literature on epilepsy in DS, focusing on prevalence, seizure types, and potential underlying mechanisms.
  • To outline diagnostic and treatment considerations for epilepsy in the DS population.

Main Methods:

  • A comprehensive literature review was conducted, searching databases like PubMed for articles published between 1960 and 2017.
  • Included studies focused on epilepsy in children with Down syndrome, identified through electronic searches and internet resources.
  • Articles were selected based on their relevance to describing seizure features in this population.

Main Results:

  • Partial seizures (47%), infantile spasms (32%), and generalized tonic-clonic seizures (21%) are common types in DS.
  • Trisomy 21 is frequently associated with epilepsy in DS, though mosaicism and translocations are also noted.
  • Potential mechanisms include structural brain abnormalities and increased carbonic anhydrase II concentrations, though not fully elucidated.

Conclusions:

  • Epilepsy diagnosis, classification, and treatment in DS align with general population guidelines.
  • While standard pharmacological treatments are used, individuals with DS may experience increased side effects, particularly with phenytoin.
  • Further research is needed to fully understand the mechanisms contributing to increased seizure susceptibility in Down syndrome.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
522
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
868
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
939
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
283